BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang L, Xiao Z, Yue Z, Zhao H, Fan Z, Zhao M, He F, Dai S, Qiu B, Yao J, Lin Q, Dong X, Liu F. Efficacy of covered and bare stent in TIPS for cirrhotic portal hypertension: A single-center randomized trial. Sci Rep. 2016;6:21011. [PMID: 26876503 DOI: 10.1038/srep21011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Xu B, Liu J, Liu S, Xiang X, Lai L. Clinical effect of single covered stent and double covered stent on TIPS in the treatment of hemorrhage due to rupture of esophageal and gastric varices in cirrhosis and its influence on immune function. Exp Ther Med 2019;18:4259-64. [PMID: 31772628 DOI: 10.3892/etm.2019.8106] [Reference Citation Analysis]
2 Zhang Y, Liu FQ, Yue ZD, Zhao HW, Wang L, Fan ZH, He FL. Safety and efficacy of transfemoral intrahepatic portosystemic shunt for portal hypertension: A single-center retrospective study. World J Clin Cases 2019; 7(12): 1410-1420 [PMID: 31363469 DOI: 10.12998/wjcc.v7.i12.1410] [Reference Citation Analysis]
3 Cheng DL, Xu H, Li CL, Lv WF, Li CT, Mukhiya G, Fang WW. Interventional Treatment Strategy for Primary Budd-Chiari Syndrome with Both Inferior Vena Cava and Hepatic Vein Involvement: Patients from Two Centers in China. Cardiovasc Intervent Radiol 2019;42:1311-21. [PMID: 31218407 DOI: 10.1007/s00270-019-02267-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Qi X, Tian Y, Zhang W, Yang Z, Guo X. Covered versus bare stents for transjugular intrahepatic portosystemic shunt: an updated meta-analysis of randomized controlled trials. Therap Adv Gastroenterol 2017;10:32-41. [PMID: 28286557 DOI: 10.1177/1756283X16671286] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
5 García-Pagán JC, Saffo S, Mandorfer M, Garcia-Tsao G. Where does TIPS fit in the management of patients with cirrhosis? JHEP Rep 2020;2:100122. [PMID: 32671331 DOI: 10.1016/j.jhepr.2020.100122] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
6 Vozzo CF, Singh T, Bullen J, Sarvepalli S, McCullough A, Kapoor B. Hospital readmission following transjugular intrahepatic portosystemic shunt: a 14-year single-center experience. Gastroenterol Rep (Oxf) 2020;8:98-103. [PMID: 32280469 DOI: 10.1093/gastro/goz062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Tang Y, Zheng S, Yang J, Bao W, Yang L, Li Y, Xu Y, Yang J, Tong Y, Gao J, Tang C. Use of concomitant variceal embolization and prophylactic antiplatelet/anticoagulative in transjugular intrahepatic portosystemic shunting: A retrospective study of 182 cirrhotic portal hypertension patients. Medicine (Baltimore) 2017;96:e8678. [PMID: 29245228 DOI: 10.1097/MD.0000000000008678] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Seifert LL, Görlich D, Jansen C, Ortmann O, Schoster M, Praktiknjo M, Gu W, Schindler P, Köhler M, Maschmeier M, Wilms C, Meyer C, Schmidt HH, Wildgruber M, Trebicka J, Heinzow H. Evaluation of impact of elective invasive examinations in patients with transjugular intrahepatic portosystemic shunt in the long-term follow up. Z Gastroenterol 2021;59:24-34. [PMID: 33429447 DOI: 10.1055/a-1330-9867] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Huang Z, Yao Q, Zhu J, He Y, Chen Y, Wu F, Hua T. Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPS) created using covered stents of different diameters: A systematic review and meta-analysis. Diagn Interv Imaging 2021;102:279-85. [PMID: 33303394 DOI: 10.1016/j.diii.2020.11.004] [Reference Citation Analysis]
10 Triantafyllou T, Aggarwal P, Gupta E, Svetanoff WJ, Bhirud DP, Singhal S. Polytetrafluoroethylene-Covered Stent Graft Versus Bare Stent in Transjugular Intrahepatic Portosystemic Shunt: Systematic Review and Meta-Analysis. J Laparoendosc Adv Surg Tech A 2018;28:867-79. [PMID: 29356589 DOI: 10.1089/lap.2017.0560] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
11 Banini BA, Alwatari Y, Stovall M, Ogden N, Gershman E, Shah RD, Strife BJ, Shojaee S, Sterling RK. Multidisciplinary Management of Hepatic Hydrothorax in 2020: An Evidence-Based Review and Guidance. Hepatology 2020;72:1851-63. [PMID: 32585037 DOI: 10.1002/hep.31434] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
12 Luo X, Zhao M, Wang X, Jiang M, Yu J, Li X, Yang L. Long-term patency and clinical outcome of the transjugular intrahepatic portosystemic shunt using the expanded polytetrafluoroethylene stent-graft. PLoS One 2019;14:e0212658. [PMID: 30811467 DOI: 10.1371/journal.pone.0212658] [Cited by in Crossref: 8] [Article Influence: 4.0] [Reference Citation Analysis]
13 Li HB, Yue ZD, Zhao HW, Wang L, Fan ZH, He FL, Dong XQ, Liu FQ. Pathological Features of Mitochondrial Ultrastructure Predict Susceptibility to Post-TIPS Hepatic Encephalopathy. Can J Gastroenterol Hepatol 2018;2018:4671590. [PMID: 30079331 DOI: 10.1155/2018/4671590] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]